Product Information
IBUPROFEN 800 MG TABLET is a generic product labeled by SOLA Pharmaceuticals LLC, priced at $0.0585 per EA under NDC 70512078010. Its NADAC has been published 59 times since Jul 9, 2025.
FDA first approved this application on Feb 5, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
800 mg/1
Manufacturer
SOLA Pharmaceuticals LLCNDC
70512078010
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA078329FDA Approved
2/5/2009
TE Code
AB
On Market Since
12/1/2024
Pharmacological Classes
Price Statistics
The NADAC for IBUPROFEN 800 MG TABLET has been published 59 times since Jul 9, 2025, and over the history we have for it it has declined 5.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0585 per EA |
|---|---|
| All-time high | $0.0620 (Jul 16, 2025) |
| All-time low | $0.0549 (Jan 21, 2026) |
| 52-week high | $0.0601 |
| 52-week low | $0.0549 |
| Median price | $0.0567 |
| Average price | $0.0572 |
| Largest weekly change | +5.1% (Aug 19, 2026) |
| Weeks tracked | 59 |
| Tracking since | Jul 9, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ibuprofen market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of IBUPROFEN 800 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for IBUPROFEN 800 MG TABLET, manufactured by SOLA Pharmaceuticals LLC, is $0.0585 per EA (NDC 70512078010), effective Aug 19, 2026.
How has the price of IBUPROFEN 800 MG TABLET changed over time?
Over the history we have for it, the NADAC for IBUPROFEN 800 MG TABLET has declined 5.6%. It has been tracked across 59 weekly CMS publications since Jul 9, 2025.
What are the highest and lowest recorded NADAC prices for IBUPROFEN 800 MG TABLET?
Since Jul 9, 2025, the NADAC for IBUPROFEN 800 MG TABLET has ranged from a low of $0.0549 (Jan 21, 2026) to a high of $0.0620 (Jul 16, 2025), with a median of $0.0567 per EA.
Are there cheaper alternatives to IBUPROFEN 800 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of IBUPROFEN 800 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures IBUPROFEN 800 MG TABLET?
IBUPROFEN 800 MG TABLET (NDC 70512078010) is labeled by SOLA Pharmaceuticals LLC, and CMS classifies it as a generic product.